Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® ...

Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...

Ryman Hospitality targets 8% group rooms revenue growth for 2026 as corporate demand strengthens

Discover Q3 2025 insights on Ryman Hospitality Properties—strong group bookings, positive outlook, and strategies for growth.

Ingredion narrows 2025 EPS guidance to $11.10-$11.30 as operational recovery and cost savings advance

Get Q3 2025 earnings insights for Ingredion (INGR): analysis of Argo facility impact, guidance updates, and growth strategies.
The Motley Fool

Which States Produce the Most Renewable Energy?

Countries around the world are increasing renewable energy production to mitigate climate change. In the U.S., renewable energy production has more than doubled over the past decade, although clean ...